Bera, Kaustav http://orcid.org/0000-0001-9831-6000
Schalper, Kurt A.
Rimm, David L. http://orcid.org/0000-0001-5820-4397
Velcheti, Vamsidhar
Madabhushi, Anant
Article History
Accepted: 4 July 2019
First Online: 9 August 2019
Competing interests
: K.A.S. has received fees as a speaker for Merck and Takeda, is a consultant for Celgene, Moderna and Shattuck Labs, and receives research funding from Genoptix (Novartis), Onkaido, Pierre Fabre, Surface Oncology, Takeda, Tesaro and Tioma. D.L.R. is a consultant and research adviser to Agendia, Agilent, AstraZeneca, Biocept, BMS, Cell Signalling Technology, Cepheid, Merck, PAIGE, Perkin Elmer and Ultivue, owns equity in AstraZeneca, Cepheid, Lilly, Navigate–Novartis, NextCure, PixelGear and Ultivue, and receives research funding from Perkin Elmer. A.M. is a consultant and scientific adviser to Elucid Bioimaging and Inspirata, owns stock options in Elucid Bioimaging and Inspirata, and receives research funding from Philips. K.B. and V.V. declare no competing interests.